BASi Expands Business Development Team in US and Canada

WEST LAFAYETTE, Ind.--(Business Wire)--
BASi is proud to announce the expansion of their business development team in
the United States. Don Hawker will represent BASi in Canada and the Western U.S.
covering California, Oregon, Washington, Idaho, Nevada, Utah, Montana, Arizona
and Wyoming. Hawker's sales and marketing background will be an asset to
expanding BASi`s contract research services (preclinical, bioanalytical, large
molecule bioanalysis, method development, pharmaceutical analysis) and
specialized instrumentation and accessories for electrochemistry andin vivo
sampling products.

Hawker brings an extensive background in sales and marketing in the life
sciences industry, including GLP large and small molecule bioanalysis,
proteomics, bioinformatics, GMP bioanalytical and more.

"Don`s unique blend of business development, sales and marketing experiences
gives BASi a definite advantage," stated BASi Vice President of Sales and
Marketing, Jon Brewer. "Don maintains excellent relationships with key
scientists, technology assessment and outsourcing professionals in large pharma
and biotech organizations - that will give him a head start on his work for
BASi."

Previously Hawker gained experience at Tandem Labs, Solvias, Inc. and
Aspectrics, Inc. At Tandem Labs he focused on small and large molecules, and
while at Solvias he specialized in GMP method development and lot release
business development activities. Hawker built Aspectrics market introduction and
positioning from the ground up, creating a strong revenue pipeline and
delivering the company`s initial business.

About BASi
BASi provides contract research services (preclinical, bioanalytical, large
molecule bioanalysis, method development, pharmaceutical analysis) and
specialized instrumentation and accessories for electrochemistry and in vivo
sampling products to the world`s leading drug development companies in the US
and Europe. The company focuses on developing innovative services and products
that increase efficiency and reduce the cost of taking new drugs to market.
Visit www.BASInc.com for more information about BASi.

BASi
Alice Schwind, 765-497-8458
aschwind@BASInc.com

Copyright Business Wire 2009